No Infections Seen After Transperineal Biopsy for Prostate Cancer
MONDAY, Sept. 30, 2024 (HealthDay News) — For patients with suspicion for prostate cancer,...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 2344 results for 'prostate cancer '
VR for Enhancing Patient Understanding in Localized Prostate Cancer and Surgical Planning
The following is a summary of “Virtual Reality as an Adjunct to traditional patient counseling in...
Read More
Predictive Modeling of Incidental Prostate Cancer Risk in Benign Prostatic Hyperplasia Surgery
The following is a summary of “Incidental Prostate Cancer in Patients Undergoing Surgery for...
Read More
Outcomes of Salvage Treatments for Recurrent Prostate Cancer
The following is a summary of “Salvage local treatment for recurrent prostate cancer after focal...
Read More
Prognostic Role of Osteopontin in Prostate Cancer Radiotherapy
The following is a summary of “Pretreatment plasma osteopontin level as a marker of response to...
Read More
Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients
1. In a retrospective analysis of 59,875 patients with metastatic prostate cancer, varying...
Read MoreMRI-measured periprostatic to subcutaneous adipose tissue thickness ratio as an independent risk factor in prostate cancer patients undergoing radical prostatectomy.
The purpose of this study is to evaluate whether the periprostatic adipose tissue thickness (PPATT) is an independent prognostic factor for prostate cancer patients after laparoscopic radical prostatectomy (LRP). This...
Read More
Olaparib Monotherapy Yields Good PSA Response Rates in Prostate Cancer
MONDAY, Aug. 26, 2024 (HealthDay News) — For men with high-risk biochemically recurrent...
Read More
Increasing Stereotactic Body Radiation Adoption Impacts Prostate Cancer Treatment Patterns
The following is a summary of “Stereotactic Body Radiation Adoption Impacts Prostate Cancer...
Read MoreAdvertisement
Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer.
Metabolic reprogramming and cellular senescence greatly contribute to cancer relapse and recurrence. In aging and treated prostate, persistent accumulating senescence-associated secretory phenotype (SASP) of cancer cells often...
Read More
Baseline MRI PI-RADS Linked to Biopsy Reclassification in Prostate Cancer
WEDNESDAY, Aug. 14, 2024 (HealthDay News) — The baseline magnetic resonance imaging (MRI)...
Read MoreDelayed definitive management of localized prostate cancer: what do we know?
Delays in the work-up and definitive management of patients with prostate cancer are common, with logistics of additional work-up after initial prostate biopsy, specialist referrals, and psychological reasons being the most...
Read MoreInsights into immune microenvironment and therapeutic targeting in androgen-associated prostate cancer subtypes.
Prostate cancer, one of the most prevalent malignancies among men worldwide, is intricately linked with androgen signaling, a key driver of its pathogenesis and progression. Understanding the diverse expression patterns of...
Read More
Significant Association Between PSA and ALP Biomarkers in Relation to Time-to-Tumor Shrinkage in Prostate Cancer
The following is a summary of “Relationship between prostate-specific antigen, alkaline...
Read More
PITPNA-AS1: Diagnostic Biomarker and Therapeutic Target in Prostate Cancer Regulates Malignant Behavior via miR-129-5p Interaction
The following is a summary of “LncRNA PITPNA-AS1 mediates the diagnostic potential of miR-129-5p...
Read MoreComparison of infection risk between enzalutamide and abiraterone in patients with prostate cancer.
Enzalutamide and abiraterone may differ in their immunomodulatory effects, and the prednisone coadministered with abiraterone can be immunosuppressive. This study aimed to compare the risk of different types of infection in...
Read More
PTCSC3 Downregulation Linked to Poor Prognosis in Prostate Cancer, Regulates Tumor Progression via miR-182-5p Interaction
The following is a summary of “Decreased levels of PTCSC3 promote the deterioration of prostate...
Read More
Out-of-Pocket Costs Considerable, Increasing for Prostate Cancer Diagnostic Testing
MONDAY, July 15, 2024 (HealthDay News) — For patients with private insurance undergoing...
Read More
Comparing Stereotactic vs. Conventional Proton Therapy for Early Prostate Cancer
The following is a summary of “Stereotactic Body Proton Therapy Versus Conventionally Fractionated...
Read More
Addressing Clinical Challenges in Prostate Cancer Care for Sexual and Gender Minorities
The following is a summary of “Clinical considerations for sexual and gender minorities with...
Read More